Author

Erika Kettner

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

2007 · Helmut Oettle, Stefan Post, et al. · JAMA · 2,411

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

2012 · Ralf-Dieter Hofheinz, Frederik Wenz, et al. · The Lancet Oncology · 508

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

2007 · Michael Herold, Antje Haas, et al. · Journal of Clinical Oncology · 501

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

2005 · Gunter von Minckwitz, Walter Jonat, et al. · Breast Cancer Research and Treatment · 168

Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer

2001 · K. Ridwelski, T. Gebauer, et al. · Annals of Oncology · 165

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.

2003 · Marko Kornmann, Wolfgang Schwabe, et al. · PubMed · 156

Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases

2011 · Ricarda Seidensticker, Timm Denecke, et al. · CardioVascular and Interventional Radiology · 147

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

2012 · Volker Heinemann, Ursula Vehling-Kaiser, et al. · Gut · 119

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

2013 · S. Kubicka, R. Greil, et al. · Annals of Oncology · 106

PDF

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer

2007 · S. Boeck, T. Hoehler, et al. · Annals of Oncology · 78

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

2004 · Michael Herold, Rita Pasold, et al. · Blood · 72

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

2007 · S. Boeck, K. Weigang-Köhler, et al. · Annals of Oncology · 68

PDF

Erlotinib as 2nd and 3rd line monotherapy in patients with metastatic colorectal cancer. Results of a multicenter two-cohort phase II trial

2005 · U. Keilholz, D. Arnold, et al. · Journal of Clinical Oncology · 41

Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma

2016 · Ricarda Seidensticker, Max Seidensticker, et al. · Gastroenterology Research and Practice · 40

PDF

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

2011 · H J Stemmler, D diGioia, et al. · British Journal of Cancer · 37

PDF

Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’

2009 · Stefan Boeck, Ursula Vehling-Kaiser, et al. · Anti-Cancer Drugs · 33

Association of Time to Recurrence With Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Expression in Stage II and III Colorectal Cancer

2002 · Marko Kornmann, Karl H Link, et al. · Journal of Gastrointestinal Surgery · 33

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer

2017 · Michael Haas, Steffen Ormanns, et al. · British Journal of Cancer · 32

PDF

Overproduction of IL-7, IL-10 and TGF-β1 in Multiple Myeloma

2009 · Hendrik Kröning, Michael Täger, et al. · Acta Haematologica · 23

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)

2015 · C. Kahl, R. Krahl, et al. · Journal of Cancer Research and Clinical Oncology · 22

Haemorrhagic Complications and Symptomatic Venous Thromboembolism in Interventional Tumour Ablations: The Impact of Peri-interventional Thrombosis Prophylaxis

2016 · Konrad Mohnike, Hanna Sauerland, et al. · CardioVascular and Interventional Radiology · 20

Docetaxel-cisplatin (DC) versus 5-fluorouracil-leucovorin-cisplatin (FLC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase III study

2008 · K. Ridwelski, J. Fahlke, et al. · Journal of Clinical Oncology · 20

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

2022 · Osman Öcal, Regina Schinner, et al. · Cancer Imaging · 19

PDF

Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma

2006 · K. Ridwelski, J. Fahlke, et al. · European Journal of Surgical Oncology · 18

Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study.

1997 · U Köhler, S S Olbricht, et al. · PubMed · 18

Works count: 76

Citation count: 4,978

H-index: 20

I10-index: 30